Care Navigation for Methamphetamine Use Disorder: A Randomized Clinical Trial - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Navigating Care for Individuals with Methamphetamine Use Disorder: Results from a Randomized Clinical Study

  • By

  • Alia Al-Tayyib

  • Deborah J. Rinehart

  • Karina G. Duarte

  • Aiden Gilbert

  • Chris Newton

  • Ryan Loh

  • Emily Bacon

  • Scott A. Simpson

  • September 2, 2026

Share

  • 1

    Stimulant-related mortality, particularly from methamphetamine, has significantly increased, marking a fourth wave in the overdose crisis.

  • 2

    No FDA-approved medications exist for treating methamphetamine use disorder, making management particularly challenging.

  • 3

    Contingency management is identified as the most effective psychosocial intervention for stimulant use disorders, yet is underutilized.

  • 4

    The BEAT Meth trial aims to compare usual care with a care navigation intervention that incorporates contingency management principles.

  • 5

    Participants in the study were adults with methamphetamine-related acute care encounters, recruited from Denver Health between April 2023 and September 2024.

Original Source(s)

Care Navigation for Methamphetamine Use Disorder: A Randomized Clinical Trial

  • by Alia Al-Tayyib, Deborah J. Rinehart, Karina G. Duarte, Aiden Gilbert, Chris Newton, Ryan Loh, Emily Bacon, Scott A. Simpson

  • September 2, 2026

Related Content

Sex-dependent effects of psychedelics: review of evidence from rodent models

Systematically developed, comprehensive atlas of unique evidence-based psychological interventions for severe mental disorders

Knowledge, attitudes, and perception toward new psychoactive substances among Saudi university students: a cross-sectional study